Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M275233-5mg | 5mg | In stock | $151.90 | |
M275233-10mg | 10mg | In stock | $205.90 | |
M275233-25mg | 25mg | In stock | $423.90 | |
M275233-50mg | 50mg | In stock | $763.90 |
Selective A 2B antagonist
Synonyms | MRS 1754|264622-58-4|MRS1754|MRS-1754|N-(4-Cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamide|N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide|7E435V2DAH|CHEMBL273807|N-(4-Cyanophenyl |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C,Desiccated |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of A 1 receptor;Antagonist of A 2A receptor;Antagonist of A 2B receptor;Antagonist of A 3 receptor |
Product Description | MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats。 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide |
---|---|
INCHI | InChI=1S/C26H26N6O4/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30) |
InChi Key | AJBBEYXFRYFVNM-UHFFFAOYSA-N |
Canonical SMILES | CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N |
Isomeric SMILES | CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N |
Alternate CAS | 264622-58-4 |
PubChem CID | 6603931 |
MeSH Entry Terms | 8-(4-(((4-cyanophenyl)carbamoylmethyl)oxy)phenyl)-1,3-di(ni-propyl)xanthine;MRS 1754;MRS-1754;MRS1754;N-(4-cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy)acetamide |
Molecular Weight | 486.52 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2320383 | Certificate of Analysis | Dec 18, 2023 | M275233 |
B2320426 | Certificate of Analysis | Dec 18, 2023 | M275233 |
B2320431 | Certificate of Analysis | Dec 18, 2023 | M275233 |
B2320511 | Certificate of Analysis | Dec 18, 2023 | M275233 |
Solubility | Soluble in DMSO to 50 mM |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed |
Precautionary Statements | P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. |
1. Yi X et al.. (2018) Adenosine receptors enhance the ATP-induced odontoblastic differentiation of human dental pulp cells.. Biochem Biophys Res Commun, 497 (3): (850-856). [PMID:29454963] |
2. Basu M et al.. (2020) Increased host ATP efflux and its conversion to extracellular adenosine is crucial for establishing Leishmania infection.. J Cell Sci, 133 (7): [PMID:32079656] |
3. Zhou Y et al.. (2019) MRS1754 inhibits proliferation and migration of bladder urothelial carcinoma by regulating mitogen-activated protein kinase pathway.. J Cell Physiol, 234 (7): (11360-11368). [PMID:30565699] |